3D Systems (DDD) investor relations material

Executive summary

• Q3 revenue was $99.3M, up 8.8% YoY reported and 10.9% excluding divested software operations; Adjusted EBITDA improved to $3.1M from a $10.0M loss.

• Strategic markets—medical technology, dental, aerospace and defense, and data center infrastructure—drove growth as additive manufacturing adoption shifts from prototyping to production.

• Q3 GAAP net loss widened to $33.5M from $18.1M, including a $12.5M Intrepid litigation accrual.

Financial highlights

• Non-GAAP gross margin was 35.5%, up 420 bps YoY excluding software divestitures; non-GAAP gross profit was $35.2M versus $28.1M on that basis.

• Non-GAAP operating expenses excluding divested software declined 14.7% YoY to $36.1M from $42.3M.

• Adjusted EBITDA was $3.1M versus a $10.0M loss in Q3 2025; year-to-date Adjusted EBITDA was $4.4M versus a $40.8M loss.

• GAAP diluted loss per share was $0.21 versus $0.14; non-GAAP diluted loss per share excluding software divestitures was $0.06 versus $0.08.

Outlook and guidance

• Q4 revenue guidance is $100M–$103M; Adjusted EBITDA guidance is a loss of $2M to breakeven.

• At the Q4 revenue midpoint, FY 2026 revenue growth is expected to approach mid-single digits; the outlook reflects positive momentum and variable customer programs and purchasing patterns.

• Healthcare Solutions is expected to deliver fairly predictable double-digit growth over the next two to three years; industrial growth may come in waves as program timing varies.

• Cash, cash equivalents and operating cash flow, with other liquidity sources as needed and subject to market conditions, are expected to cover requirements for the next 12 months.